These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29695018)

  • 21. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
    Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
    Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis.
    Wallach JD; Luxkaranayagam AT; Dhruva SS; Miller JE; Ross JS
    BMC Med; 2019 Jun; 17(1):117. PubMed ID: 31203816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reporting Compliance of Stroke Trials: Cross-Sectional Analysis.
    Malhotra K; Rayi A; Khunger M; Thompson S; Liebeskind DS
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1472-1480. PubMed ID: 28412315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trial Reporting in ClinicalTrials.gov - The Final Rule.
    Zarin DA; Tse T; Williams RJ; Carr S
    N Engl J Med; 2016 Nov; 375(20):1998-2004. PubMed ID: 27635471
    [No Abstract]   [Full Text] [Related]  

  • 27. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sponsorship and design characteristics of trials registered in ClinicalTrials.gov.
    Roumiantseva D; Carini S; Sim I; Wagner TH
    Contemp Clin Trials; 2013 Mar; 34(2):348-55. PubMed ID: 23380028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized clinical trials in obstetrics-gynecology registered at ClinicalTrials.gov: Characteristics and factors associated with publication.
    Gupta M; Petsalis M; Powers K; Chen HY; Chauhan SP; Wagner S
    Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():223-228. PubMed ID: 32559607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Reported Trial Characteristics, Rate of Publication, and Inclusion of Mandatory Biopsies of Research Biopsies in Clinical Trials in Oncology.
    Parseghian CM; Tam AL; Yao J; Ensor J; Ellis LM; Raghav K; Overman MJ
    JAMA Oncol; 2019 Mar; 5(3):402-405. PubMed ID: 30383128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of clinical trials associated with early results reporting at ClinicalTrials.gov.
    Bashir R; Dunn AG
    Contemp Clin Trials; 2022 Jun; 117():106785. PubMed ID: 35526836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
    Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
    Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of pivotal clinical trial results reporting for newly approved medications varied by reporting source.
    Withycombe B; Ovenell M; Meeker A; Ahmed SM; Hartung DM
    J Clin Epidemiol; 2016 Sep; 77():78-83. PubMed ID: 27108488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.
    Rayi A; Thompson S; Gloss D; Malhotra K
    Epilepsy Res; 2018 Jul; 143():1-6. PubMed ID: 29625272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public availability of results of observational studies evaluating an intervention registered at ClinicalTrials.gov.
    Baudart M; Ravaud P; Baron G; Dechartres A; Haneef R; Boutron I
    BMC Med; 2016 Jan; 14():7. PubMed ID: 26819213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial registry use in anaesthesiology systematic reviews: A cross-sectional study of systematic reviews published in anaesthesiology journals and the Cochrane Library.
    Umberham BA; Detweiler BN; Sims MT; Vassar M
    Eur J Anaesthesiol; 2017 Dec; 34(12):797-807. PubMed ID: 28731924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor Result Reporting Rate in Cell Therapy Trials Registered at ClinicalTrials.gov.
    Negoro T; Okura H; Hayashi S; Arai T; Matsuyama A
    Tissue Eng Part B Rev; 2023 Dec; 29(6):623-633. PubMed ID: 37166388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. E-cigarette manufacturers' compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs.
    DeVito NJ; Drysdale H; McKee M; Goldacre B
    Tob Control; 2023 Jan; 32(1):60-66. PubMed ID: 34127550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.